<DOC>
	<DOCNO>NCT01313182</DOCNO>
	<brief_summary>We hypothesize application mupirocin povidone-iodine naris equally effective short term Staphylococcus aureus ( SA ) suppression . Our overall study objective measure rate deep superficial Surgical Site Infections ( SSIs ) primary hip , knee , shoulder elbow arthroplasty surgery primary spinal fusion surgery require implantation prosthetic material , patient receives either nasal mupirocin nasal povidone-iodine prior surgery . Secondary study objective include : 1 . Measure hospital length stay re-admission rate mupirocin povidone-iodine group . 2 . Measure adverse event related mupirocin povidone-iodine . 3 . Measure rate SA resistance mupirocin .</brief_summary>
	<brief_title>Prevention Surgical Site Infections : Effectiveness Nasal Povidone-Iodine Nasal Mupirocin</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Surgical Wound Infection</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Mupirocin</mesh_term>
	<mesh_term>Cadexomer iodine</mesh_term>
	<mesh_term>Povidone-Iodine</mesh_term>
	<mesh_term>Iodine</mesh_term>
	<mesh_term>Anti-Infective Agents , Local</mesh_term>
	<mesh_term>Povidone</mesh_term>
	<criteria>Primary arthroplasty spinal fusion surgery Age great 18 year Revision arthroplasty Revision spinal fusion surgery Primary spine surgery without implantation prosthetic material Allergy mupirocin Allergy povidoneiodine Pregnancy Breastfeeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2014</verification_date>
</DOC>